AI Article Synopsis
- A specialized analytical system for real-time urea monitoring during haemodialysis is described, utilizing the dialyser's inflow as a continuous carrier solution.
- The system incorporates a bioreactor with immobilized urease and a gas-diffusion module, converting urea to ammonia gas for measurement by an ion-sensitive electrode.
- Validation of the on-line analyser was established through correlation with conventional spectrophotometric methods for measuring urea clearances, confirming its effectiveness in optimizing haemodialysis sessions.
Article Abstract
An analytical system specially built for on-line urea monitoring is reported. Measurements are carried out in the effluent of a haemodialysis machine. The measuring system employs the dialyser inflow stream as a carrier solution channel in a continuous fashion. The analyser periodically samples the outflow stream of the dialyser by means of an automatic injection valve. The analyser features a bioreactor consisting of immobilized urease and a gas-diffusion module. It is through this module that the urea is converted to ammonia gas which is transferred to another carrier channel, this transports the ammonium ion to a tubular, all-solid-state, ion-sensitive electrode. A timer controls the transport, injection, the measuring and the recording subsystems. The analyser has been used during actual haemodialysis sessions. Urea clearances were also measured in batch, using conventional spectrophotometric clinical equipment. The correlation between both methodologies was sufficient to confirm the usefulness of the developed on-line analyser to monitor the optimal length of haemodialysis sessions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0731-7085(93)80050-b | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Longitudinal impact of extended-hours hemodialysis with a liberalized diet on nutritional status and survival outcomes: findings from the LIBERTY cohort.
Clin Exp Nephrol
January 2025
Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, 464-8550, Japan.
Background: Protein-energy wasting (PEW), a unique weight loss linked to nutritional and metabolic abnormalities, is common in patients undergoing hemodialysis (HD) and associated with adverse outcomes. This study investigated whether extended-hours HD combined with a liberalized diet could overcome PEW and improve survival.
Methods: The body mass index (BMI) and survival outcomes in patients undergoing extended-hours HD were evaluated for up to 8 years using data from the LIBeralized diet Extended-houRs hemodialysis Therapy (LIBERTY) cohort.
The association between systolic and diastolic dysfunction and autonomic nervous system function in children receiving chronic hemodialysis.
Pediatr Nephrol
January 2025
Cardiology Department, Faculty of Medicine (Girls), Al-Azhar University, Cairo, Egypt.
Background: Changes in cardiac function and structure as well as their association with the cardiac autonomic nervous system remain incompletely characterized in children with stage 5 chronic kidney disease (CKD) receiving hemodialysis (HD).
Methods: A prospective observational cohort study was conducted on 40 Egyptian children with CKD on regular HD compared to 40 age- and sex-matched healthy children. All participants underwent thorough clinical examination, laboratory investigations, 24-h Holter monitoring, and 2D/4D echocardiographic study (conventional and advanced modalities).
Use of Hemoadsorption and Continuous Venovenous Hemodialysis With Enhanced Middle Molecule Clearance in Drug-Induced Rhabdomyolysis.
Case Rep Crit Care
January 2025
Department of Anesthesiology and Intensive Care Medicine, Kreiskliniken Günzburg-Krumbach, Krumbach, Germany.
Drug-induced rhabdomyolysis has become increasingly prevalent due to the rising use of medications such as statins, antidepressants, and antipsychotics. These can lead to muscle cell destruction and the release of myoglobin, potentially causing kidney damage. Recent advancements include the use of CytoSorb hemoadsorption as a promising therapy to remove myoglobin and other potentially toxic substances from the bloodstream.
View Article and Find Full Text PDFVariable treatment response to lumasiran in pediatric patients with primary hyperoxaluria type 1.
Pediatr Nephrol
January 2025
University Medical Center Hamburg-Eppendorf, University Children's Hospital, Martinistrasse 52, Hamburg, 20246, Germany.
Background: Primary hyperoxaluria type 1 (PH 1) is a rare genetic condition due to mutations in the AGXT gene. This leads to an overproduction of oxalate in the liver. Hyperoxaluria often causes kidney stones, nephrocalcinosis, and chronic kidney disease.
View Article and Find Full Text PDFImplementation of An Advance Care Planning Intervention in Dialysis Clinics.
Am J Kidney Dis
January 2025
School of Nursing, University of Wisconsin-Madison, Madison, WI, U.S.A.
Rationale & Objective: Sharing Patient's Illness Representations to Increase Trust (SPIRIT) is an evidence-based advance care planning intervention targeting dialysis patients and their surrogate decision-makers. To address SPIRIT's implementation potential, we report on a process evaluation in our recently completed five-state cluster-randomized trial.
Study Design: A descriptive study of implementation within a randomized clinical trial.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!